Scrophularia root

Scrophularia Root (Scrophularia ningpoensis Hemsl.): A Comprehensive Reference

1. Identity: Botanical Classification, Names, and Natural Source

Primary species and nomenclature. Scrophularia ningpoensis, commonly known as the Ningpo figwort or Chinese figwort, is a perennial plant in the figwort family, Scrophulariaceae. The genus Scrophularia (Scrophulariaceae family) consists of more than 200 species of perennial herbs that are distributed across temperate Asia, Europe (mostly in the Mediterranean region), and North America. When used as a dietary supplement or in herbal medicine, the term "scrophularia root" refers most commonly to S. ningpoensis (the dominant TCM species) but may also encompass the closely related European species Scrophularia nodosa L. (common figwort or knotted figwort) and, in East Asian contexts, Scrophularia buergeriana Miquel.

Synonyms and pharmacopoeial designations. The dried root of S. ningpoensis bears several official and common names: Scrophulariae Radix (Latin pharmacopoeial term, abbreviated SR); Radix Scrophulariae ningpoensis (RSN); and the Chinese names Xuanshen (玄参) and Zhexuanshen. Scrophularia ningpoensis Hemsley, known as "Zhexuanshen," is used in the Chinese Materia Medica (CMM), belonging to the family Scrophulariaceae, and has a long history of widespread use in China. S. ningpoensis was named by Forbes and Hemsley (1890) based on specimens collected in Tiantong County, Ningbo City of Zhejiang Province, and is endemic to China and now widely cultivated in China as well.

Botanical description and natural distribution. Scrophularia ningpoensis Hemsl. is a perennial herb native to Southeastern China. It reaches 1 m by 0.4 m; its flowers are hermaphrodite, insect-pollinated, and the plant usually flowers in late spring. In China, SR is mainly produced in Zhejiang, Hubei, Chongqing, Sichuan, Shanxi, Guizhou, and other places. Like other herbal medicines, S. ningpoensis collected from different localities may considerably differ in therapeutic efficacy, and the one grown in Zhejiang Province is recognized as geo-authentic.

Medicinal part and common preparations. Radix Scrophulariae (RS), derived from the dried root of Scrophularia ningpoensis Hemsl., is a well-known and frequently used traditional Chinese medicine colloquially named as Xuanshen. Its root is harvested in autumn in Zhejiang province and neighboring areas, then dried for later use. The root is commercially available in multiple forms: as dried sliced root pieces prepared as decoctions or teas, as standardized aqueous or hydroalcoholic extracts, in capsule and tablet dosage forms, and as a component of multi-herb traditional formulas. The dried roots of Scrophularia ningpoensis Hemsl. are commonly used as tea in Traditional Chinese Medicine.

The European species: Scrophularia nodosa. Scrophularia nodosa (also called figwort, woodland figwort, and common figwort) is a perennial herbaceous plant found in temperate regions of the Northern Hemisphere except western North America. Species such as Scrophularia ningpoensis and Scrophularia nodosa are most frequently used in herbal medicine.

Adulteration and quality concern. It is common that Scrophulariae Radix is often contaminated by various adulterants like S. buergeriana, S. kakudensis, and S. yoshimurae in its medicinal usage.

2. Traditional and Historical Use

2.1 Traditional Chinese Medicine (TCM)

Scrophulariae Radix (SR) is the dried root of S. ningpoensis, and it is widely used in China, Korea, Japan, and other regions for more than 2000 years. SR was first recorded in Shen-Nong-Ben-Cao-Jing in the Han dynasty. This classical pharmacopoeial text, compiled approximately during the Han dynasty (206 BCE–220 CE), represents the first known written reference to the root's medicinal use.

In traditional Chinese medicine theory, the property of SR is cold and sweet, and it has multiple efficacies. SR possesses the effect of clearing away heat and cooling blood, nourishing Yin and reducing fire, detoxicating and resolving a mass in TCM.

In practice, these TCM indications translated to a wide spectrum of clinical applications. SR is widely used to treat fever, pharyngitis, cardiovascular diseases, eye diseases, diphtheria, and other diseases. It is used to treat inflammation, laryngitis, tonsillitis, abscesses of carbuncles, and constipation. Known for its antipyretic and anti-inflammatory effects, RSN is widely used for the treatment of laryngitis, fever, swelling, constipation, and neuritis.

Small doses of RSN act as a heart tonic, while higher doses rather suppress heart function. This dose-dependent duality is a documented feature in classical TCM literature and has since attracted pharmacological investigation.

More than 70 prescriptions containing SR have been recorded in the Chinese Pharmacopoeia (2015 edition), reflecting its long-established effectiveness and safety profile within the TCM tradition. Canonical multi-herb formulas incorporating scrophularia root include Zeng Ye Tang (Increase the Fluids Decoction), used for yin-deficiency dryness, and Qing Ying Tang (Clear the Nutritive Level Decoction), formulated for febrile disorders affecting the ying (nutritive) level.

2.2 Korean and Japanese Traditional Medicine

In Chinese traditional medicine, the dried root of S. buergeriana Miquel is used for the treatment of neuritis, fever, and pharyngitis. The related species Scrophularia buergeriana has been employed in Korean folk medicine, particularly for neurological and inflammatory conditions, and has been the subject of separate pharmacological investigations.

2.3 European Herbal Tradition

Scrophularia nodosa, commonly known as figwort or knotted figwort, has a long history in traditional herbal medicine, particularly in Europe, where it was employed for its diuretic, anodyne, and anti-inflammatory properties. It was traditionally used to treat various skin conditions, including eczema, psoriasis, pruritus, and scrofula (a form of tuberculosis affecting the lymph nodes), as well as wounds, swellings, hemorrhoids, and rheumatism.

The genus name Scrophularia and the common name "figwort" both derive from the plant's historical use against scrofula—the archaic term for tubercular cervical lymphadenopathy. In European folk medicine, figwort (Scrophularia nodosa) was historically called "throatwort" or "knotted figwort" and was used to treat scrofula—tubercular swelling of the lymph nodes—hence the genus name. The plant's roots and aerial parts were valued for alleviating inflammations and promoting detoxification, with applications documented in historical pharmacopoeias for conditions like pharyngitis, neuritis, and laryngitis.

The earliest documented mention of Scrophularia nodosa appears in John Parkinson's 17th-century herbal, "Theatrum Botanicum," where he notes its affinity for treating swellings and skin inflammations—hence the old name "figwort," referencing its use on fig-like lumps and scrofula. In European folk medicine, figwort was carried in pouches to "ward off contagion," and a decoction was applied topically to soothe sores and ulcers.

3. Phytochemistry: Key Constituents and Active Compounds

More than 162 compounds have been identified and isolated from S. ningpoensis, including iridoids and iridoid glycosides, phenylpropanoid glycosides, organic acids, volatile oils, terpenoids, saccharides, flavonoids, sterols, and saponins. The primary pharmacologically active classes are discussed below.

3.1 Iridoid Glycosides

Iridoids are the most abundant and distinctive active chemical constituents in Scrophulariae Radix. They primarily consist of five-membered and six-membered rings and exhibit notable anticancer, anti-inflammatory, and hepatoprotective effects. Among these compounds, aucubin, geniposide, and catalpol are representative iridoids that are present mainly in glycosidic forms and release active compounds upon hydrolysis.

Harpagoside is widely regarded as the principal chemical marker and major bioactive constituent. Harpagoside, an iridoid glycoside, is the major bioactive constituent of the traditional Chinese medicine Scrophulariae Radix. As the principal bioactive constituent, harpagoside serves as a key marker for assessing the pharmacological quality of S. ningpoensis Hemsl. The Pharmacopoeia of the People's Republic of China (2020 edition) and the Taiwan Herbal Pharmacopeia (2021 edition) both designate harpagide and harpagoside as the official chemical markers for the standardization of S. ningpoensis starting material.

Harpagide (C₁₅H₂₄O₁₀), harpagoside (C₂₄H₃₀O₁₁), aucubin (C₁₅H₂₂O₉), and catalpol (C₁₅H₂₂O₁₀) are the four key iridoids extensively studied for their pharmacological effects. Three iridoid constituents from Scrophularia ningpoensis Hemsl.—harpagoside, acetylharpagide, and harpagide—were investigated for their neuroprotective potential against rotenone-induced cytotoxicity, with catalpol serving as reference compound.

3.2 Phenylpropanoid (Phenylethanoid) Glycosides

One of the main constituents of Scrophularia plants is phenylethanoid glycosides, and many of the therapeutic potentials can be attributed to them. The chief members of this class present in SR include acteoside (acetoside; C₂₉H₃₆O₁₅), angoroside C (C₃₆H₄₈O₁₉), cistanoside D, and related cinnamic acid glycosides. The plant's main constituents are iridoids and phenylpropanoids. Seven isolated compounds of RSN studied include harpagide, harpagoside, angoroside C, aucubin, catalpol, acetoside, and cinnamic acid.

3.3 Phenolic Acids, Flavonoids, Sterols, and Other Compounds

Eleven compounds were isolated and identified, including vanillin, eugenol, isoeugenol methyl ether, ferulic acid, benzoic acid, syringic acid, rhamnopyranosyl vanilloyl, syringic acid-4-O-alpha-L-rhamnopyranoside, beta-sitosterol, adenosine, and dibutyl phthalate. Up to now, iridoids, phenolic glycosides, phenolic acids, alkaloids, flavonoids, triterpenes, and other compounds have been isolated and identified from S. ningpoensis. Flavonoids isolated from SN have been reported to have anti-hypertension effects and terpenoids have anti-oxidative activity.

Polysaccharides represent a further pharmacologically active fraction. Few studies have focused on the activity of polysaccharides from S. ningpoensis (SNPS). Polysaccharides are among the most active substances found in nature, with a variety of biological activities, such as antitumor, antioxidation, anti-inflammation, and immune regulation, with relatively low toxicity and side effects.

Oligosaccharides (including raffinose, stachyose, and verbascose) have also been characterized from the roots. SnS-2, an oligosaccharide mixture including raffinose, stachyose, and verbascose from the roots of Scrophularia ningpoensis, had antitumor activity against the growth of Lewis pulmonary carcinoma cells transplanted into mice.

4. Established Mechanisms of Action

4.1 Anti-Inflammatory Pathways

The apoptotic and anti-inflammatory effects of Scrophularia extract have been demonstrated on HaCaT cells. The extract induced those effects potentially through affecting the MAPK pathway and inhibition of the NF-κB pathway. These are two of the most central pro-inflammatory signaling cascades in mammalian biology.

Specific iridoids modulate cytokine production directly. Aucubin-related iridoid ribosides inhibit the production of tumor necrosis factor-α (TNF-α), interleukin-1β (IL-1β), and interleukin-6 (IL-6). They also block the activation of NF-κB in lipopolysaccharide (LPS)-stimulated macrophages, thereby reducing tissue inflammation.

For harpagoside specifically: harpagoside could inhibit acute and chronic inflammation. Harpagoside suppressed mice paw edema induced by carrageenan and decreased the IL-6 level in model mice plasma. Harpagoside could decrease clinical signs of inflammation in the acute phase. Harpagoside attenuated cell infiltration in synovium and cartilage, and decreased cartilage loss and erosion in model mice. In addition, harpagoside reduced the loss of glycosaminoglycans in the cartilage and decreased proteoglycan in arthritic mice.

Polysaccharide fractions also contribute via inflammatory cytokine suppression. Real-time RT-PCR and ELISA showed that SNPS significantly improved LPS-stimulated inflammatory response by decreasing mRNA and protein expression of IL-6 and TNF-α in a dose-dependent manner.

Regarding anti-inflammatory activity attributable to phenylpropanoids: all cinnamic acid glycosides showed potent reactive oxygen species (ROS) scavenging ability in AAPH assay. Therefore, the anti-inflammatory activities of cinnamic acids from S. ningpoensis may be attributed to their oxygen radical scavenging abilities.

4.2 Antioxidant Mechanisms

Catalpol can activate antioxidant enzymes (such as superoxide dismutase [SOD] and catalase [CAT]), reduce the level of oxidative stress in the body, and protect cells. Fast repair of oxidized OH radical adducts of dAMP and dGMP by angoroside C and acetoside generated by RSN was demonstrated, suggesting an anti-oxidative effect of Scrophularia ningpoensis.

4.3 Immunomodulatory Mechanisms

PSR (polysaccharides of SR) promoted the growth of the spleen index, thymus index, and carbon clearance index and increased humoral immune function in normal and hyperthyroid mice. PSR also increased the degree and rate of ear swelling in mice and increased the contents of IL-2, IFN-γ, IgG, and IgM in the serum and promoted the proliferation of B and T lymphocytes in mice spleen.

4.4 Antiplatelet and Cardiovascular Mechanisms

6-O-trans-cinnamoyl-1-O-α-D-fructofuranosyl-β-D-glucopyranose, harpagide, harpagoside, angoroside C, cistanoside D, and acteoside were reported to inhibit platelet aggregation induced by adenosine diphosphate. Angoroside C increased the content of cAMP in rabbit platelets, decreased the levels of TXB2 and 6-keto-prostaglandin F1α (6-keto-PGF1α) in the serum, and increased the ratio of 6-keto-PGF1α/TXB2.

5. Scientific Evidence by Area of Use

Important note on evidence level: The large majority of pharmacological evidence for scrophularia root derives from in vitro cell-culture experiments and in vivo animal studies. Robust human clinical trial data are sparse. Where human data exist, they involve SR as part of multi-herb formulas, making it impossible to isolate its independent effects. Reviewers in the peer-reviewed literature have consistently called for further dedicated clinical trials.

5.1 Cardiovascular System

Modern pharmacological studies have confirmed that S. ningpoensis is a valuable Chinese medicinal herb with many pharmacological uses in the treatment of cardiovascular, diabetic, and liver diseases.

Renowned for its properties in cooling blood, nourishing yin, and detoxification, SR is clinically employed in treating cardiovascular and cerebrovascular diseases, diabetes mellitus, and hyperthyroidism, among others.

In the area of hypertension and cardiac remodeling: active extract of Radix Scrophularia (ACRS) demonstrated beneficial effects on ventricular remodeling induced by coronary artery ligation and lowered blood pressure in rats. ACRS also exhibited the effect on lowering the blood pressure in spontaneously hypertensive rats (SHRs). The aim of the study was to explore the effects of ACRS on ventricular remodeling in SHRs and underlying mechanisms. This constitutes animal-level evidence only; no published placebo-controlled human clinical trial isolating scrophularia root's antihypertensive effect has been identified in the peer-reviewed literature.

Numerous clinical trials and pharmacological activity experiments have demonstrated that Scrophulariae Radix possesses antiangiogenic effect, anti-inflammatory effect, antimicrobial activities, ventricular remodeling activities, and antineurodegenerative disease activities, as well as effects of treating neoplasm. However, where "clinical trials" are referenced in this context, they generally refer to observations within TCM clinical practice or small-scale Chinese-language studies rather than rigorously designed, double-blind, randomized controlled trials meeting current international standards.

5.2 Inflammation and Immune Regulation

Studies published on Scrophularia buergeriana (SB) and Scrophularia ningpoensis (SN) in the latest 20 years were reviewed. SB presented anti-inflammatory activities, immune-enhancing effects, bone disorder prevention activity, neuroprotective effect, anti-amnesic effect, and anti-allergic effect; SN showed a neuroprotective effect, anti-apoptotic effect, anti-amnesic effect, and anti-depressant effect; and SR exhibited an immune-enhancing effect and cardioprotective effects through in vitro and in vivo experiments.

The evidence base for anti-inflammatory effects rests primarily on in vitro work. Angoroside C and acetoside revealed anti-inflammatory activities in rats. Other activities such as anti-angiogenesis, neuroprotection, as well as anti-depressant, anti-amnestic, cardiovascular, cytotoxic, and anti-tumor properties also have been reported. Despite numerous investigations demonstrating the bioactivity of RSN, the molecular and cellular mechanisms of action are still poorly understood.

Evidence strength: Preclinical (in vitro and animal). No dedicated human RCTs on scrophularia root's anti-inflammatory efficacy in isolation have been identified in the available literature.

5.3 Diabetes and Metabolic Health

S. ningpoensis is a commonly used medicinal plant in China for the treatment of diabetes mellitus (DM), but its mechanism of action remains poorly described. Accumulating evidence suggests that the extracts obtained from S. ningpoensis exert an array of activities, including cardiovascular protection, hepatoprotection, anti-inflammatory and anti-oxidative activity, immunomodulation, hypoglycemic effects, and neuroprotective activity.

Network pharmacology studies have further characterized the diabetes-related mechanisms. Key active ingredients of S. ningpoensis in diabetes treatment include β-sitosterol, stigmasterol, taxifolin, harpagoside, and 14-deoxy-12(R)-andrographolide sulfonate. The study identifies 14 common diabetes-related targets, such as prostaglandin endoperoxide synthase 2 (PTGS2), acetylcholinesterase (ACHE), and the β2-adrenergic receptor (ADRB2).

A variety of iridoid glycosides from the root have been found to possess strong protective effects upon impaired pancreatic function and peripheral insulin resistance. Reviews have summarized the effects of iridoid glycosides upon T2DM and potential mechanisms, discussing their structure-activity relationship.

A 2022 cell-biology study (ScienceDirect) demonstrated that an aqueous extract of S. ningpoensis improved insulin sensitivity through AMPK-mediated inhibition of the NLRP3 inflammasome, providing a mechanistic link between its anti-inflammatory and antidiabetic properties. However, this work was conducted in cellular and animal models, not in humans.

Regarding gut microbiota: polysaccharides from S. ningpoensis (SNP) showed evidence of decreasing the Firmicutes/Bacteroidota ratio and promoting proliferation of beneficial bacteria. Based on these findings, the action mechanism of SNP against T2DM was clarified by reshaping microbiota and regulating intestinal metabolites. This constitutes preclinical evidence.

Evidence strength: Preclinical (in vitro and animal models, network pharmacology). No published standalone human clinical trial isolating scrophularia root for T2DM management was identified.

5.4 Neuroprotection and Neurological Applications

Harpagoside, an iridoid purified from the Chinese medicinal herb S. ningpoensis Hemsl., demonstrated promising preventative effects and a rescuing effect on dopaminergic neuron neurodegeneration and movement disorder using the MPP+-intoxicated primary cultured rat mesencephalic neurons in vitro and a chronic MPTP mouse model in vivo. Harpagoside significantly attenuated the loss of tyrosine hydroxylase (TH)-positive neuron numbers and the shortening of axonal length in cultured mesencephalic neurons.

Three iridoid constituents from Scrophularia ningpoensis Hemsl.—harpagoside, acetylharpagide, and harpagide—were investigated for their neuroprotective potential against rotenone-induced cytotoxicity (a Parkinson's disease cellular model), with catalpol serving as reference compound.

In the area of memory and cognitive function, polysaccharides of S. ningpoensis (SNPS) have been shown to exhibit antidepressant properties in preclinical reserpine-induced depression models. Researchers previously isolated polysaccharides from S. ningpoensis Hemsl. (SNPS) and observed that SNPS exhibit antidepressant properties.

Radix Scrophulariae has been previously identified as a potential neuroprotective natural plant, and results from ongoing studies may offer insight into discovering new active compounds or drugs for the treatment of ischemic stroke.

Clinical studies have shown that catalpol can inhibit the activity of thyroid peroxidase and treat thyroid diseases. However, this claim requires caution, as "clinical studies" in this context may refer to Chinese-language observational studies rather than high-quality RCTs.

Evidence strength: Primarily preclinical (in vitro neuron culture, rodent behavioral models). Human clinical trial evidence is not available for stand-alone neuroprotective claims.

5.5 Hepatoprotection

Numerous experimental and clinical studies have indicated that RS possesses various biological activities, including hepatoprotective activity, anti-inflammatory, neuroprotective, and antipyretic effects. Sun et al. described the hepatoprotective effects of phenylpropanoids from RSN on aminotransferases. These findings are primarily from in vitro and animal studies.

Evidence strength: Preclinical. No specifically designed human RCTs for hepatoprotection were identified.

5.6 Anticancer / Antitumor Research

Scrophulariae Radix, the dried root of Scrophularia ningpoensis Hemsl., is known for its diverse pharmacological effects, such as antihypertensive, anti-inflammatory, and antitumor properties.

Several mechanisms have been proposed. Compounds from SR inhibit HaCaT cell proliferation and induce apoptosis, supporting their antitumor potential. Additionally, aucubin from S. ningpoensis suppressed A549 non-small cell lung cancer cell growth. The induction of apoptosis and inhibition of proliferation in various cancer cell lines, as demonstrated by its compounds like aucubin, provide a rationale for its antitumor investigation.

However, tumor cell-line selectivity was not universal in all tested models. Tumor cell line selectivity was not observed when the cytotoxic effect on melanoma cell lines was studied. The apoptotic and anti-inflammatory effects of Scrophularia extract were demonstrated on HaCaT cells.

SnS-2, an oligosaccharide mixture including raffinose, stachyose, and verbascose from the roots of Scrophularia ningpoensis, had antitumor activity against the growth of Lewis pulmonary carcinoma cells transplanted into mice.

Evidence strength: Preclinical only (cell lines and animal tumor models). No human oncology clinical trials for scrophularia root as a primary agent were identified.

5.7 Thyroid Disease

Outer conditions studied include hyperthyroidism, hyperthyroid-induced hepatic disease, goiter, thyroid cancer, diabetes, diabetic retinopathy, and diabetic nephropathy. Inner mechanistic roles include anti-inflammatory, hepatoprotective, immunomodulation, anti-tumor, hypoglycemic, antioxidant, with components including iridoids and phenylpropanoids. The polysaccharides of SR (PSR) strengthened the immune function in normal and hyperthyroid mice. PSR promoted the growth of the spleen index, thymus index, and carbon clearance index and increased humoral immune function in normal and hyperthyroid mice.

Evidence strength: Preclinical animal models and limited mechanistic studies; human clinical evidence is not established.

5.8 Immune Enhancement and Anti-Fatigue

The polysaccharides of SR (PSR) exhibited an anti-fatigue effect in the heavy-loaded mice swimming model. PSR increased the swimming time of model mice and increased activity of GSH-Px in mouse heart, liver, spleen and quadriceps muscle. PSR also increased the activity of CAT in the liver and reduced the content of MDA in the myocardium, skeletal muscle, and liver.

Evidence strength: Animal experimental data only.

6. Body Systems and Health Areas Associated with Scrophularia Root

Based on the totality of TCM tradition and peer-reviewed pharmacological research, scrophularia root has been associated with the following body systems and health domains:

• Cardiovascular system: cardiovascular protection, including antihypertensive and anti-ventricular remodeling effects.
• Immune system: immunomodulation, stimulating B cell activity.
• Nervous system: neuroprotective effect, anti-apoptotic effect, anti-amnesic effect, and antidepressant effect.
• Endocrine/metabolic system: clinical employment in treating cardiovascular and cerebrovascular diseases, diabetes mellitus, hyperthyroidism.
• Liver/hepatic system: hepatoprotective activity.
• Upper respiratory tract: antipyretic and anti-inflammatory effects; treatment of laryngitis, fever, and swelling.
• Hematological/platelet system: inhibition of platelet aggregation induced by adenosine diphosphate by multiple compounds including harpagide, harpagoside, angoroside C, cistanoside D, and acteoside.
• Skin and lymphatic system (primarily S. nodosa): Scrophularia nodosa was traditionally employed for its diuretic, anodyne, and anti-inflammatory properties, used to treat eczema, psoriasis, pruritus, scrofula, wounds, swellings, hemorrhoids, and rheumatism.

7. Dosage Forms and Dosages Reported in Sources

There is no universally agreed-upon standardized clinical dosage for scrophularia root as a standalone supplement. Doses reported in sources reflect traditional prescribing practice and in vitro or in vivo experimental parameters:

• Dried root (traditional decoction/tea): Its dried roots are known in China as Xuanshen, a traditional medicine that has been used as an antipyretic and for the treatment of sore throat and prurigo for over 1000 years. In traditional TCM practice, decoctions are prepared from the dried root slice.
• Scrophularia nodosa — Western herbal preparations (as reported by a naturopathic reference): An infusion of 1 tbsp steeped for 15 minutes, taken three times daily; a tincture at 2–4 mL three times daily (1:5, 45%); a dried herb dose of 2–8 g three times daily; or capsules at 250 mg (2 capsules three times daily). These dosages reflect traditional Western herbal medicine practice and are not derived from clinical trials.
• Ethanol extract in vitro (SBE for anti-inflammatory): The 70% ethanol extract of SB (SBE, 10–80 μg/mL) regulated various inflammatory factors in RAW 264.7 cells.
• Chinese Pharmacopoeia (2015): More than 70 prescriptions containing SR have been recorded in the Chinese Pharmacopoeia (2015 edition). The Chinese Pharmacopoeia specifies harpagide and harpagoside as the chemical markers for quality determination.

No established dose for humans from controlled clinical trials could be identified in the peer-reviewed sources accessed for this article.

8. Safety Considerations and Known Interactions

8.1 General Safety Profile

The potential toxicity of SN has not been fully characterized. Further studies, such as toxicological studies and clinical trials, on the efficacy and safety of SR, including SB and SN, need to be conducted. Most of the S. ningpoensis activity may be attributed to iridoid glycosides and phenylpropanoid glycosides; however, detailed information on the molecular mechanisms, metabolic activity, toxicology, and structure-function relationships of active components is limited.

8.2 Dose-Dependent Cardiac Effects

Small doses of RSN act as a heart tonic, while higher doses rather suppress heart function. This bidirectional, dose-dependent cardiac action—cardiotonic at low doses and cardiodepressant at high doses—represents the most consistently documented safety signal in traditional and experimental literature. It is distinct from, though conceptually similar to, the well-characterized cardiac glycoside effect of related plants.

8.3 Gastrointestinal Effects

In order to minimize side-effects such as diarrhea, nausea, or abdominal pain, traditional TCM prescribing added Amomi xanthioidis fructus (sha ren) to the prescription. This pharmacopoeial caution reflects a recognized potential for GI adverse effects with scrophularia root preparation.

8.4 Herb–Drug Interactions

Scrophularia ningpoensis (Xuan shen) is listed among Chinese herbs that may interact with anti-diabetic drugs. This is consistent with its demonstrated hypoglycemic properties in preclinical models, which raises the theoretical concern of additive hypoglycemia when used concurrently with insulin or oral antidiabetic agents. This interaction concern is advisory in nature; controlled human pharmacokinetic interaction studies were not identified.

8.5 Contraindications from Traditional Sources

Within classical TCM theory, scrophularia root (SR) is categorized as having a "cold" thermal property. Traditional contraindications include use in patients with conditions characterized by cold constitutional patterns, loose stools, or deficiency of spleen yang. Pregnancy and lactation contraindications are acknowledged in some Western herbal references on the related species Scrophularia nodosa, though clinical data confirming teratogenicity or reproductive harm in humans are absent from the peer-reviewed sources accessed.

8.6 Adulteration Risk

It is common that Scrophulariae Radix is often contaminated by various adulterants like S. buergeriana, S. kakudensis, and S. yoshimurae in its medicinal usage. However, traditional methods for identifying Chinese medicinal materials have been found to be insufficient in accurately distinguishing S. ningpoensis from the three adulterant species. Species substitution presents a practical safety and efficacy concern, as the phytochemical profiles and biological activities of these species differ.

8.7 Overall Research Gaps

Further studies, such as toxicological studies and clinical trials, on the efficacy and safety of SR, including SB and SN, need to be conducted. Most of the S. ningpoensis activity may be attributed to iridoid glycosides and phenylpropanoid glycosides; however, detailed information on the molecular mechanisms, metabolic activity, toxicology, and structure-function relationships of active components is limited. Further comprehensive research to evaluate the medicinal properties of S. ningpoensis is needed.

References

• Xue G-Q et al. Chemical constituents of Scrophularia ningpoensis root. Zhong Yao Cai. 2014;37:1597–1599. PubMed PMID: 25857160
• Ren D et al. Pharmacology, phytochemistry, and traditional uses of Scrophularia ningpoensis Hemsl. Journal of Ethnopharmacology. 2021;269:113688. ScienceDirect
• Ren D, Shen ZY, Qin LP, Zhu B. Pharmacology, phytochemistry, and traditional uses of Scrophularia ningpoensis Hemsl. J Ethnopharmacol. 2021 Apr 6;269:113688. PubMed PMID: 33338592
• Zhang Q, Liu A, Wang Y. Scrophularia ningpoensis Hemsl: a review of its phytochemistry, pharmacology, quality control and pharmacokinetics. Journal of Pharmacy and Pharmacology. 2021;73(5):573–600.
• Lee HJ, Kim HL, Lee DR, Choi BK, Yang SH. Scrophulariae Radix: An Overview of Its Biological Activities and Nutraceutical and Pharmaceutical Applications. Molecules. 2021 Aug 30;26(17):5250. PMC8434300
• Lewenhofer V et al. Effects of Scrophularia ningpoensis Hemsl. on Inhibition of Proliferation, Apoptosis Induction and NF-κB Signaling of Immortalized and Cancer Cell Lines. Pharmaceuticals. 2012;5(2):189–208. PMC3763631
• Active components from Radix Scrophulariae inhibits the ventricular remodeling induced by hypertension in rats. PMC4801831
• Active components from Radix Scrophulariae inhibits the ventricular remodeling induced by hypertension in rats. PubMed PMID: 27066371
• Molecular authentication of geo-authentic Scrophularia ningpoensis. PMC3087096
• Polysaccharides of Scrophularia ningpoensis Hemsl.: Extraction, Antioxidant, and Anti-Inflammatory Evaluation. Evidence-Based Complementary and Alternative Medicine. 2020. PMC7755497
• The mechanism and application of Scrophulariae Radix in the treatment of endocrine disorders: focusing on thyroid diseases and diabetes mellitus. Frontiers in Endocrinology. 2025.
• Chemometric-guided chemical marker selection: A case study of the heat-clearing herb Scrophularia ningpoensis. Frontiers in Plant Science. 2023;14:1153710. PMC10088908
• Aqueous extract of Scrophularia ningpoensis improves insulin sensitivity through AMPK-mediated inhibition of the NLRP3 inflammasome. Phytomedicine. 2022. ScienceDirect
• Using RAD-seq to identify and differentiate the medicinal herb Scrophularia ningpoensis and its adulterants. BMC Genomics. 2025. Springer
• Scrophularia Root — an overview. ScienceDirect Topics
• Reduced levels of nitrated α-synuclein in the protective effect of harpagoside on rotenone-induced cellular models of Parkinson's disease. PMC12640970
• Polysaccharides of Scrophularia ningpoensis Hemsl.: Extraction, Antioxidant, and Anti-Inflammatory Evaluation. PubMed PMID: 33381217
• An Update on Oligosaccharides and Their Esters from Traditional Chinese Medicines. PMC4377491
• Polysaccharides from Scrophularia ningpoensis Hemsl. improve reserpine-induced depression-like behavior. PubMed PMID: 39884598
• Scrophularia ningpoensis. Wikipedia
• Scrophularia nodosa. Wikipedia
• Chinese and Western Herbal Medicine: A Guide to Potential Risks and Drug Interactions. EthnoMed
• In vitro fermentation characteristics of polysaccharide from Scrophularia ningpoensis and its effects on type 2 diabetes mellitus gut microbiota. PMC12060902